Pharmaceutically effective compounds

Details Pharmaceutically effective compounds Pharmaceutically effective compounds

2007-10-30

2009-06-23

Habte, Kahsay T (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S229200, C544S066000

Reexamination Certificate

active

07550457

ABSTRACT:
The subject invention relates to carboxamidine derivatives, to pharmaceutical compositions containing the carboxamidine derivatives of the invention, and the use thereof for the treatment of vascular diseases and in the preparation of pharmaceutical compositions for the treatment of vascular diseases.

REFERENCES:
patent: 4187220 (1980-02-01), Takacs et al.
patent: 4404384 (1983-09-01), Gebert et al.
patent: 4451286 (1984-05-01), Martin et al.
patent: 5147879 (1992-09-01), Nagy et al.
patent: 5239077 (1993-08-01), Bertok et al.
patent: 5278309 (1994-01-01), Bertok et al.
patent: 5296606 (1994-03-01), Nagy et al.
patent: 5328906 (1994-07-01), Nagy et al.
patent: 5334600 (1994-08-01), Van Duzer et al.
patent: 5919796 (1999-07-01), Barabas et al.
patent: 6649628 (2003-11-01), Kurthy et al.
patent: 6653326 (2003-11-01), Vigh et al.
patent: 7126002 (2006-10-01), Urogdi et al.
patent: 7148239 (2006-12-01), Vigh et al.
patent: 2059184 (1992-07-01), None
patent: 0369944 (1990-05-01), None
patent: 1540028 (1979-02-01), None
patent: 1582029 (1980-12-01), None
patent: WO 90/04584 (1990-05-01), None
patent: WO 90/08131 (1990-07-01), None
patent: WO 92/03130 (1992-03-01), None
patent: WO 95/30649 (1995-11-01), None
patent: WO 97/00251 (1997-01-01), None
patent: WO 97/13504 (1997-04-01), None
patent: WO 97/16439 (1997-05-01), None
patent: WO 98/06400 (1998-02-01), None
patent: WO 98/43948 (1998-10-01), None
patent: WO 98/47362 (1998-10-01), None
patent: WO 00/35914 (2000-06-01), None
patent: WO 00/50403 (2000-08-01), None
patent: WO 01/79174 (2001-10-01), None
patent: WO 2005/041965 (2005-05-01), None
Chalmers (TiPS vol. 17, pp. 166-172 Apr. 1996).
Beltrao et al., “Preparation and Spectral Study of O-methyl=benzamidoximes,”Chemical Abstracts, 89:215038s (1978).
Burger, “Pro-Drugs,”A Guide to the Chemical Basis of Drug Design, p. 15, 1.3.1 (1983).
Chalmers et al., “Corticotrophin-releasing factor receptors: from molecular biology to drug design”,TIPS, 17:166-172 (1996).
Dekoning, et al., “Org. 2766 improves Functional and Electrophysical Aspects of Regenerating Sciatic Nerve in the Rat,”Peptides, 8(3):415-422 (1987).
Morrison, et al.,Organic Chemistry, Allyn and Bacon, Inc. (Boston), 205-211, (1983).
Showa Denko K.K., “Insecticidal (hydroxyimino) butanones,”, ChemicalAbstracts, 102:220443m (1985).
Sorensen et at., “Soluble expression of recombinant proteins in the cytoplasm ofEscherichia coli,” Microbial Cell Factories, 4:1-8(2005).
Stanley, “Sensory and Motor Nerve Conduction Velocities and the Latency of the H-Reflex During Growth of the Rat,”Experimental Neurology, 71(2):497-506 (1981).
Tesfamariam, et al., “Contraction of Diabetic Rabbit Aorta Caused by Endothelium-Derived PGH2-TxA2,”American Journal of Physiology, 257(5):1327-1333 (1989).
Winslow, et al., “Comparative Effects of the Isomers of Bepridil on Isolated Coronary and Aortic Arteries,”European Journal of Pharmacology, 166(2):241-249 (1989).

Affiliated with

Also associated with

Rating

Pharmaceutically effective compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutically effective compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically effective compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4085299